Epidemiological features of rotavirus infection in Caracas, Venezuela: Implications for rotavirus immunization programs

Journal of Medical Virology

Volumn 59, Issue 4, 1999, Pages 520-526

  Pérez Schael, Irene ^a   González, Rosabel ^a   Fernández, Rosa ^a   Alfonzo, Edgar ^a   Inaty, David ^a   Boher, Yordy ^b   Sarmiento, Luis ^c  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

^b Universidad Nacional Experimental Simon Rodriuez   (Venezuela)

^c Hospital de Ninos J M de los Rios   (Venezuela)

Author keywords

Epidemiology; Rotavirus dis ease; Venezuela

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CLINICAL FEATURE; DEHYDRATION; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; PREVALENCE; ROTAVIRUS; SOCIAL CLASS; VENEZUELA; VIRUS INFECTION; VOMITING;

AGE DISTRIBUTION; CHILD, PRESCHOOL; DIARRHEA, INFANTILE; FECES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEASONS; SEROTYPING; SEX DISTRIBUTION; SOCIAL CLASS; VENEZUELA;

EID: 0345633599     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199912)59:4<520::AID-JMV16>3.0.CO;2-7     Document Type: Article

References (37)

1. Bass DM, Baylor M, Broome R, Greenberg HB. 1992. Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse. J Clin Invest 89:1741-1745.
2. Bern C, Glass RI. 1994. Impact of diarrheal disease worldwide. In: Kapikian AZ, editor. Viral infections of the gastrointestinal tract. 2nd ed. New York: Marcel Dekker. p 1-26.
3. Bishop RF, Davidson GP, Holmes IH, Ruck BJ. 1973. Virus particles in epithelial cells of duodenal mucosa from children with viral gastroenteritis. Lancet 1281-1283.
4. Cook SM, Glass RI, LeBaron CW, Ho MS. 1990. Global seasonality of rotavirus infections. Bull WHO 68:171-77.
5. Flores J, Taniguchi K, Green K, Pérez-Schael I, García D, Sears J, Urasawa S, Kapikian AZ. 1988. Relative frequencies of rotavirus serotypes 1, 2, 3, and 4 in venezuelan infants with gastroenteritis. J Clin Microbiol 26:2092-2095.
6. Glass RI, Gentsch J, Smith JC. 1994. Rotavirus vaccines: success by reassortment? Science 265:1389-1391.
7. Glass RI, Bresee JS, Parashar U, Miller M, Gentsch JR. 1997. Rotavirus vaccines at the threshold. Nature Med 3:1324-1325.
8. Guerrant RL, Schorling JB, McAuliffe JF, De Souza MA. 1992. Diarrhea as a cause and effect of malnutrition: diarrhea prevents catch-up growth and malnutrition increases diarrhea frequency and duration. Am J Trop Med Hyg 47:28-35.
9. Hoshino Y, Wyatt RG, Greenberg HB, Flores J, Kapikian AZ. 1984. Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis 149:694-702.
10. Institute of Medicine. 1986. The prospects for immunizing against rotavirus. New vaccine development: establishing priorities. Diseases of importance in developing countries. Vol 2. Washington, DC: National Academy Press. p 308-318.
11. Joensuu J, Koskenniemi E, Pang XL, Vesikari T. 1997. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 350:1205-1209.
12. Kapikian AZ, Yolken RH, Greenberg HB, Wyeth RG, Kalica AR, Chanock RM, Kim HW. 1979. Gastroenteritis viruses. In: Lennette EH, Schmidt NJ, editors. Diagnostic procedures for viral, rickettsial and chlamydial infections. 5th ed. Washington, DC: American Public Health Association. p 927-995.
13. Kapikian AZ, Hoshino Y, Chanock RM, Pérez Schael I. 1996. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 174:865-72.
14. Lanata CF, Midthun K, Black RE, Butron B, Huapaya A, Penny ME, Ventura G, Gil A, Jett-Goheen, Davidson BL. 1996. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Perú. J Infect Dis 174:268-275.
15. Le Baron CW, Lew J, Glass RI, Weber J, Ruiz-Palacios G, the rotavirus study group. 1990. Annual rotavirus epidemic patterns in North America. Results of a 5-year retrospective survey of 88 centers in Canadá, México, and the United States. JAMA 264:983-988.
16. Linhares AC, Gabbay YB, Mascarenhas JDP, de Freitas RB, Oliveira CS, Bellesi N, Monteiro TAF, Lins-Lainson Z, Ramos FLP, Valente SA. 1996. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil. Bull WHO 74:491-500.
17. Losonsky GA, Rennels MB, Lem Y, Krall G, Kapikian AZ, Levine MM. 1988. Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006. Pediatr Infect Dis J 7:388-393.
18. Matson DO, Estes MK. 1990. Impact of rotavirus infection at a large pediatric hospital. J Infect Dis 162:598-604.
19. Méndez-Castellano H, De Méndez MC. 1986. Estratificación social y biología humana: método Graffar modificado. Arch Venez Puericult Pediatr 49:93-104.
20. Pereira HG, Linhares AC, Candeias JAN, Glass RI. 1994. Vigilancia de los virus de la gastroenteritis en los laboratorios nacionales del Brasil. Bull Pan Am Health Org 116:27-36.
21. Pérez Schael I. 1996. The impact of rotavirus disease in Venezuela. J Infect Dis 174:S19-21.
22. Pérez-Schael I, García D, González M, González R, Daoud N, Perez M, Cunto W, Kapikian AZ Flores J. 1990. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol 30:219-229.
23. Pérez Schael I, Rojas AM, Flores J. 1991. Desarrollo de una vacuna anti-rotavirus. Pruebas de campo en Venezuela. Acta Cient Venez 42:296-312.
24. Ṕerez Schael I, Guntiñas MJ, Pérez M, Pagone V, Rojas AM, Cunto W, Hoshino Y, Kapikian AZ. 1997. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 337:1181-1187.
25. Pericchi LR, Pérez-Schael I, Viana G, Cunto W, Kapikian AZ, Flores J. 1989. Statistical analysis of a rhesus rotavirus vaccine trial to assess protective effect against diarrhea in venezuelan children of 2-4 months of age. Interciencia 14:199-202.
26. Rennels M. 1996a. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 174:S107-111.
27. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Oichichero ME, Zito ET, Mack ME, Davidson BL, Kapikian AZ. 1996. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines. Report of the national multicenter trial. Pediatrics 97:7-13.
28. Rimer HC, Wasserman SS, Flores J, Pichichero ME, Losonsky GA. 1992. Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion. J Infect Dis 165:826-830.
29. Rojas AM, Boher Y, Guntiñas MJ, Pérez Schael I. 1995. Homotypic immune response to primary infection with rotavirus serotype G1. J Med Virol 47:404-409.
30. Ryan MJ, Ramsay M, Brown D, Gay NJ, Farrington CP, Wall PG. 1996. Hospital admissions attributable to rotavirus infection in England and Wales. J Infect Dis 174:S12-18.
31. Santosham M, Moulton LH, Reid R, Croll J, Weatherholt, Ward R, Forro J, Zito E, Mack M, Brenneman G, Davidson BL. 1997. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr 131:632-638.
32. Torok TJ, Kilgore PE, Clarke MJ, Holman RC, Bressee JS, Glass RI, and the National Respiratory and Enteric Virus Surveillance System Collaborating Laboratories. 1997. Visualizing geographic and temporal trends in rotavirus activity in the United States, 1961 to 1996. Pediatr Infect Dis J 16:941-946.
33. Unicomb LE, Kilgore PE, Faruque ASG, Hamadani JD, Fuchs GJ, Albert J, Glass RI. 1997. Anticipating rotavirus vaccines: hospital-based surveillance for rotavirus diarrhea and estimates of disease burden in Bangladesh. Pediatr Infect Dis J 16:947-951.
34. Velázquez FR, Matson DO, Calva JJ, Guerrero ML, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM, 1996. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 335:1022-1028.
35. Viera de Torres B, Mazzali de Ilja R, Esparza J. 1978. Epidemiological agents of rotavirus infection in hospitalized Venezuelan children with gastroenteritis. Am J Trop Med Hyg 27:567-572.
36. White L, García L, Boher Y, Blanco M, Pérez M, Romer H, Flores J, Perez-Schael I. 1991. Temporal distribution of human rotavirus serotypes 1, 2, 3, and 4 in Venezuelan children with gastroenteritis during 1979-1989. J Med Virol 34:79-84.
37. WHO. 1990. A manual for the treatment of diarrhoea: for use by physicians and other senior health workers. Geneva: World Health Organization.